Skip to Content

Clinical Trials Search Results

Showing 1-3 of 3

Sorted By:

  • BMS 143

    An Expanded Access Program for Elotuzumab in Combination with Lenalidomide plus Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma

  • CTSU E1A11

    Randomized Phase III Trial of Bortezomib, LENalidomide and Dexamethasone (VRd) Versus Carfilzomib, Lenalidomide and Dexamethasone (CRd) Followed by Limited or Indefinite DURation Lenalidomide MaintenANCE in Patients with Newly Diagnosed Symptomatic Multiple Myeloma (ENDURANCE)

  • SWOG S1304

    A Phrase II randomized study comparing Two doses of Carfilzomib (NSC-756640) with Dexamethasone for Multiple Myeloma patients with Relapsed or Refractory disease

Showing trials 1-3 of 3

Also in this Section